Discover
VTGN
Vistagen Therapeutics, Inc.
0.21
1 x 0.25
2 x 0.38
bid
ask
-
0.01
5.21%
2 @ 06:00 AM
0.21 -0.00 (1.77%)
| Ytd | -67.45% | |
| 1y | -94.51% |
0.21
day range
0.23
0.20
52 week range
5.14
| Open | 0.22 | Prev Close | 0.23 | Low | 0.21 | High | 0.23 | Mkt Cap | 9.53M |
| Vol | 1.03M | Avg Vol | 12.50M | EPS | -1.66 | P/E | N/A | Forward P/E | -1.49 |
| Beta | 0.33 | Short Ratio | 1.69 | Inst. Own | 53.63% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 0.26 | 200-d Avg | 0.48 | 1yr Est | 13.00 |
| Income Statement | |||
| Total Revenue | 1.48M | ||
| Revenues (USD) | 1.48M | ||
| Gross Profit | 1.48M | ||
| Operating Expenses | 14.82M | ||
| Research and Development Expense | 10.91M | ||
| Selling, General and Administrative Expense | 3.92M | ||
| Operating Income | -13.35M | ||
| Net Income | -13.03M | ||
| Net Income Common Stock | -13.03M | ||
| Net Income Common Stock (USD) | -13.03M | ||
| Consolidated Income | -13.03M | ||
| Earnings per Basic Share | -0.30 | ||
| Earnings per Basic Share (USD) | -0.30 | ||
| Earnings per Diluted Share | -0.30 | ||
| Earning Before Interest & Taxes (EBIT) | -13.03M | ||
| Earning Before Interest & Taxes (USD) | -13.03M | ||
| Weighted Average Shares | 42.98M | ||
| Weighted Average Shares Diluted | 42.98M | ||
| Balance Sheet | |||
| Cash and Equivalents | 16.99M | ||
| Cash and Equivalents (USD) | 16.99M | ||
| Investments | 14.74M | ||
| Investments Current | 14.74M | ||
| Current Assets | 34.31M | ||
| Property, Plant & Equipment Net | 1.03M | ||
| Total Assets | 35.74M | ||
| Debt Current | 720.00K | ||
| Total Debt | 783.00K | ||
| Current Liabilities | 11.19M | ||
| Debt Non-Current | 63.00K | ||
| Total Liabilities | 11.26M | ||
| Accumulated Retained Earnings (Deficit) | -490.35M | ||
| Accumulated Other Comprehensive Income | -7.00K | ||
| Shareholders Equity | 24.48M | ||
| Shareholders Equity (USD) | 24.48M | ||
| Assets Non-Current | 1.43M | ||
| Total Debt (USD) | 783.00K | ||
| Deferred Revenue | 234.00K | ||
| Liabilities Non-Current | 63.00K | ||
| Trade and Non-Trade Payables | 1000.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 197.00K | ||
| Net Cash Flow from Financing | 909.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -13.80M | ||
| Issuance (Purchase) of Equity Shares | 1.00M | ||
| Issuance (Repayment) of Debt Securities | -96.00K | ||
| Net Cash Flow from Operations | -14.71M | ||
| Share Based Compensation | 991.00K | ||